Part One
The Visibility Paradox
Risk Remains High Despite Digital Investment
In previous LogiPharma research, 92% of respondents reported that the risk of product loss, theft, or temperature excursions had increased in today's volatile operating environment.
At the same time, 82% said quality and reliability had either deteriorated or improved only marginally despite significant investment in temperature-controlled supply chains.
Yet organizations themselves believe they are making progress. More than half of respondents (56%) reported being better equipped to manage transport risk than they were three years ago, while only 27% reported no meaningful improvement.
This suggests that even if reliability gains are marginal, digital investments are helping organizations cope with a more complex operating environment.
The survey indicates that risk increasingly emerges where organizations interact
Nearly half of respondents (49%) identified handover points between partners as the most common source of incidents. During investigations, 50% cited partner data collection as the largest source of friction, while a further 33% pointed to inconsistent documentation across stakeholders.
Q: Where do incidents most often occur despite existing controls?
Q: Where do incidents most often occur despite existing controls?
Pharma Respondents
At handover points
At airports
During road feeder services
During customs or regulatory holds
Failures are rare and predictable
Freight Forwarder Respondents
At handover points
At airports
During road feeder services
During customs or regulatory holds
Failures are rare and predictable
Handover points, evidence collection, and documentation consistency all depend on coordination across manufacturers, logistics providers, quality teams, airports, ground handlers, and distribution partners.
As supply chains become more interconnected, operational performance and risk management increasingly depends on how effectively information, decisions, and responsibilities move across the wider ecosystem.
Q: What creates the most friction in post-shipment investigations?
"Post-shipment investigations expose one of the biggest gaps in pharma supply chain maturity: the industry has more data than ever, but not always in a form that can support fast, confident decisions. When evidence has to be reconstructed across partners, systems, and handovers, teams lose time before root cause analysis can truly begin. The next step is not simply collecting more data, but creating a shared, standardized evidence layer across the ecosystem."
Mohamed Nouh Head of Enterprise Pharma Sales SkyCelll
